Mark Cuban Value Plus Drug Firm (MCCPDC) introduced it’s working with Coherus Biosciences, Inc. to promote Yusimry, a biosimilar model of the top-selling drug Humira, at a reduced value.
Yusimry is used to deal with a number of illnesses, resembling rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s illness and plaque psoriasis.
The treatment will probably be accessible by means of MCCPDC beginning July 2023, costing $569.27 plus shelling out and delivery charges. Will probably be the primary biologic product provided by the low cost drug provider.
In February, MCCPDC introduced a brand new program on Twitter, aiming to create an unbiased pharmacists’ community the place members can be offered a “Crew Cuban Advantages Card.” MCCPDC mentioned in a press release that Yusimry can be included in the advantages program by means of collaborating pharmacies.
“Coherus’s Yusimry is a recreation changer. Having an alternative choice to Humira that’s reasonably priced will enhance the lives of sufferers in every single place. Costplusdrugs.com is really excited to make Yusimry accessible to everybody in a clear method,” Mark Cuban advised MobiHealthNews in an e-mail.
THE LARGER TREND
Since MCCPDC’s launch in 2022, it is developed quite a few partnerships and collaborations.
In April, the corporate introduced a collaboration with Seattle-based Zócalo Health, a digital healthcare service for Latino sufferers, to increase Zócalo members’ entry to lower-cost prescription treatment.
That very same month, Fierce Healthcare reported MCCPDC teamed up with RevSpring, a well being cost options firm, to run a program with U.S. pharmacies to make medicine extra reasonably priced for customers.
MCCPDC has additionally established partnerships with California-based EmsanaRx and Tennessee-based RxPreferred Benefits and introduced collaborations with diabetes and continual illness administration firm Diathrive Health and most cancers care help firm OncoPower.
MCCPDC was additionally built-in into Rightway Health‘s platform, permitting the pharmacy profit supervisor’s members entry to MCCPDC.
Final yr, the corporate additionally introduced its first well being plan partnership with Capital Blue Cross, noting Capital’s members may use their insurance coverage playing cards at MCCPDC immediately as of the beginning of 2023.